New Horizon Health's total inventories for the quarter that ended in Jun. 2023 was HK$77 Mil. New Horizon Health's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Jun. 2023 was HK$78 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. New Horizon Health's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was HK$4.27.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
New Horizon Health's Days Inventory for the
six
months ended in Jun. 2023 was 173.07.
Inventory Turnover measures how fast the company turns over its inventory within a year.
New Horizon Health's Inventory Turnover for the quarter that ended in Jun. 2023 was 1.05.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
New Horizon Health's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.09.
New Horizon Health (HKSE:06606) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
New Horizon Health's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
New Horizon Health's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
New Horizon Health Total Inventories Related Terms
New Horizon Health Total Inventories Historical Data
* Premium members only.
The historical data trend for New Horizon Health's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
New Horizon Health (HKSE:06606) has a Total Inventories of HK$77 Mil as of Jun. 2023. The total amount of inventory as recorded on a company's balance sheet. View historical data for New Horizon Health and its competitors.
Is New Horizon Health's Total Inventories too high?
New Horizon Health's current Total Inventories is HK$77 Mil. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's Total Inventories compare to ABT and SYK?
New Horizon Health's Total Inventories of HK$77 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for New Horizon Health and its competitors. New Horizon Health's current Total Inventories is HK$77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (HKSE:06606) has a current Total Inventories of HK$77 Mil. The current Total Inventories is HK$77 Mil. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For New Horizon Health (HKSE:06606), the current Total Inventories is HK$77 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score
Get the complete analysis for HKSE:06606
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06606 has been successfully added to your 
